Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

Despite the great efforts for better treatment options for diffuse large B-cell lymphoma (DLBCL) (most common form of non-Hodgkin lymphoma, NHL) to treat and prevent relapse, it continues to be a challenge. Here, we present an overview of DLBCL and address the diagnostic assays and molecular techniq...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodhi, Niraj, Tun, Moe, Nagpal, Poonam, Inamdar, Arati A., Ayoub, Nehad M., Siyam, Noor, Oton-Gonzalez, Lucia, Gerona, Angela, Morris, Dainelle, Sandhu, Rana, Suh, Kwangsun Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646825/
https://www.ncbi.nlm.nih.gov/pubmed/33216822
http://dx.doi.org/10.18632/oncotarget.27785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646825/
https://www.ncbi.nlm.nih.gov/pubmed/33216822
http://dx.doi.org/10.18632/oncotarget.27785

Ejemplares similares